Structure of human cytidine deaminase bound to a potent inhibitor

Journal of Medicinal Chemistry

Volumn 48, Issue 3, 2005, Pages 658-660

  Chung, Sang J ^a,b   Fromme, J Christopher ^a   Verdine, Gregory L ^a  

^a HARVARD UNIVERSITY   (United States)

^b Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CYTIDINE DEAMINASE; DIAZEPINE DERIVATIVE; DIAZEPINONE RIBOSIDE; ENZYME INHIBITOR; PHENYLALANINE; UNCLASSIFIED DRUG;

ARTICLE; BINDING AFFINITY; CRYSTAL STRUCTURE; ENZYME ACTIVE SITE; ENZYME BINDING; ENZYME STRUCTURE; PROTEIN INTERACTION; STRUCTURE ANALYSIS;

AZEPINES; BINDING SITES; CRYSTALLOGRAPHY, X-RAY; CYTIDINE DEAMINASE; ENZYME INHIBITORS; HUMANS; MODELS, MOLECULAR; MOLECULAR STRUCTURE; PROTEIN CONFORMATION;

EID: 13444265938     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm0496279     Document Type: Article

References (23)

1. Cacciamani, T.; Vita, A.; Cristalli, G.; Vincenzetti, S.; Natalini, P.; Ruggieri, S.; Amici, A.; Magni, G. Purification of human cytidine deaminase: molecular and enzymic characterization and inhibition by synthetic pyrimidine analogs. Arch. Biochem. Biophys. 1991, 290, 285-292.
2. Wentworth, D. F.; Wolfenden, R. Cytidine deaminases (from Escherichia coli and human liver). Methods Enzymol. 1978, 51, 401-407.
3. Wisdom, G. B.; Orsi, B. A. Cytidine aminohydrolase from sheep liver. Biochem. J. 1967, 104, 7P.
4. Eliopoulos, N.; Cournoyer, D.; Momparler, R. L. Drug resistance to 5-aza-2′-deoxycytidine, 2′, 2′-difluorodeoxycytidine, and cytosine arabinoside conferred by retroviral-mediated transfer of human cytidine deaminase cDNA into murine cells. Cancer Chemother. Pharmacol. 1998, 42, 373-378.
5. Momparler, R. L.; Laliberte, J. Induction of cytidine deaminase in HL-60 myeloid leukemic cells by 5-aza-2′-deoxycytidine. Leukemia Res. 1990, 14, 751-754.
6. Kees, U. R.; Ford, J.; Dawson, V. M.; Piall, E.; Aherne, G. W. Development of resistance to 1-β-D-arabinofuranosylcytosine after high-dose treatment in childhood lymphoblastic leukemia: analysis of resistance mechanism in established cell lines. Cancer Res. 1989, 49, 3015-3019.
7. Aduma, P. J.; Gupta, S. V.; Stuart, A. L.; Tourigny, G. Anti-herpes virus activity of 5-methoxymethyl-2′-deoxycytidine in combination with deaminase inhibitors. Antiviral Chem. Chemother. 1990, 1, 255-262.
8. Malathi, V. G.; Silber, R. Effects of murine viral leukemia on spleen nucleoside deaminase. Purification and properties of the enzyme from leukemic spleen. Biochim. Biophys. Acta 1971, 238, 377-387.
9. Laliberte, J.; Marquez, V. E.; Momparler, R. L. Potent inhibitors for the deamination of cytosine arabinoside and 5-aza-2′-deoxycytidine by human cytidine deaminase. Cancer Chemother. Pharmacol. 1992, 30, 7-11.
10. Driscoll, J. S.; Marquez, V. E.; Plowman, J.; Liu, P. S.; Kelley, J. A.; Barchi, J. J., Jr. Antitumor properties of 2(1H)-pyrimidinone riboside (zebularine) and its fluorinated analogues. J. Med. Chem. 1991, 34, 3280-3284.
11. Frick, L.; Yang, C.; Marquez, V. E.; Wolfenden, R. V. Binding of pyrimidin-2-one ribonucleoside by cytidine deaminase as the transition-state analogue 3,4-dihydrouridine and contribution of the 4-hydroxyl group to its binding affinity. Biochemistry 1989, 28, 9423-9430.
12. McCormack, J. J.; Marquez, V. E.; Liu, P. S.; Vistica, D. T.; Driscoll, J. S. Inhibition of cytidine deaminase by 2-oxopyrimidine riboside and related compounds. Biochem. Pharmacol. 1980, 29, 830-832.
13. Wolfenden, R. V. Transition state analogues for enzyme catalysis. Nature 1969, 223, 704-705.
14. Ashley, G. W.; Bartlett, P. A. A phosphorus-containing pyrimidine analog as a potent inhibitor of cytidine deaminase. Biochem. Biophys. Res. Commun. 1982, 108, 1467-1474.
15. Betts, L.; Xiang, S.; Short, S. A.; Wolfenden, R.; Carter, C. W., Jr. Cytidine deaminase. The 2.3 Å crystal structure of an enzyme: transition-state analog complex. J. Mol. Biol. 1994, 235, 635-656.
16. Carter, C. W., Jr. The nucleoside deaminases for cytidine and adenosine: structure, transition state stabilization, mechanism, and evolution. Biochimie 1995, 77, 92-98.
17. Xiang, S.; Short, S. A.; Wolfenden, R.; Carter, C. W., Jr. Transition-state selectivity for a single hydroxyl group during catalysis by cytidine deaminase. Biochemistry 1995, 34, 4516-4523.
18. Johansson, E.; Mejlhede, N.; Neuhard, J.; Larsen, S. Crystal Structure of the Tetrameric Cytidine Deaminase from Bacillus subtilis at 2.0 Å resolution. Biochemistry 2002, 41, 2563-2570.
19. Kim, C. H.; Marquez, V. E.; Mao, D. T.; Haines, D. R.; McCormack, J. J. Synthesis of pyrimidin-2-one nucleosides as acid-stable inhibitors of cytidine deaminase. J. Med. Chem. 1986, 29, 1374-1380.
20. Marquez, V. E.; Liu, P. S.; Kelley, J. A.; Driscoll, J. S.; MeCormack, J. J. Synthesis of 1,3-diazepin-2-one nucleosides as transition-state inhibitors of cytidine deaminase. J. Med. Chem. 1980, 23, 713-715.
21. Liu, P. S.; Marquez, V. E.; Kelley, J. A.; Driscoll, J. S. Cyclic urea nucleosides. Cytidine deaminase activity as a function of aglycon ring size. J. Org. Chem. 1980, 45, 5225-5227.
22. Liu, P. S.; Marquez, V. E.; Driscoll, J. S.; Fuller, R. W.; McCormack, J. J. Synthesis of 1,3-diazepin-2-one nucleosides as transition-state inhibitors of cytidine deaminase. J. Med. Chem. 1981, 24, 662-666.
23. Yue, L.; Saikawa, Y.; Ota, K.; Tanaka, M.; Nishimura, R.; Uehara, T.; Maeba, H.; Ito, T.; Sasaki, T.; Koizumi, S. A functional single-nucleotide polymorphism in the human cytidine deaminase gene contributing to ara-C sensitivity. Pharmacogenetics 2003, 13, 29-38.